Chinese Japanese Germany Korea

Eptifibatide non cyclic impurity

Eptifibatide non cyclic impurity Structure
Eptifibatide non cyclic impurity structure
CAS No.
135900-78-6
Chemical Name:
Eptifibatide non cyclic impurity
Synonyms
Eptifibatide Impurity 10;Eptifibatide non cyclic impurity;L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-
CBNumber:
CB29436006
Molecular Formula:
C35H51N11O9S2
Molecular Weight:
833.98
MDL Number:
MOL File:
135900-78-6.mol
Request For Quotation

Eptifibatide non cyclic impurity Properties

Density 1.55±0.1 g/cm3(Predicted)
pka 4.20±0.10(Predicted)

Eptifibatide non cyclic impurity Preparation Products And Raw materials

Raw materials

Preparation Products

Eptifibatide non cyclic impurity Suppliers

Global( 7)Suppliers
Supplier Tel Email Country ProdList Advantage
China National Standard Pharmaceutical Corporation Limited 		+8615391658522 overseasales@yongstandards.com China 11927 58
Hubei Yangxin Medical Technology Co., Ltd. 15374522761 3003392093@qq.com China 8256 55
Nanjing Huanuo Biomedical Technology Co., Ltd 18913906212 2885426135@qq.com China 6789 58
Shenzhen Excellent Biomedical Technology Co., Ltd. 18318671572 2850803126@qq.com China 5012 58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd 18162595016; 18162595016 3287908757@qq.com China 9116 58
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd 18102736234 18102736234 2208093734@qq.com China 7664 58
Supplier Advantage
China National Standard Pharmaceutical Corporation Limited 		58
Hubei Yangxin Medical Technology Co., Ltd. 55
Nanjing Huanuo Biomedical Technology Co., Ltd 58
Shenzhen Excellent Biomedical Technology Co., Ltd. 58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd 58
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd 58

135900-78-6(Eptifibatide non cyclic impurity)Related Search:

L-Aspartic acid, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-, (1→3')-disulfide with L-tryptophyl-L-prolyl-L-cysteinamide (9CI) Eptifibatide impurity 3/Deamidated Eptifibatide Impurity/(3R,11S,17S,20S,25aS)-20-((1H-indol-3-yl)Methyl)-17-(carboxymethyl)-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosine-3-carbo Cyclo(L-Pro-L-Trp-) L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, bimol. cyclic (1→1'),(6→6')-bis(disulfide) N-[2-(Phenylmethyl)phenyl]-2-chloroacetamide
Acetamide, 2-methoxy-N-[2-(phenylmethyl)phenyl]- Methanone, (2-aminophenyl)phenyl-, hydrazone, (Z)- L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→7)-disulfide (9CI) Benzamide, N-[(6,11-dihydro-5H-dibenz[b,e]azepin-6-yl)methyl]-2-(hydroxymethyl)- 7-Bromo Epinastine
3'-Hydroxyacetophenone 6-Chloromethylmorphanthridine Acetamide, 2-(1-methylethoxy)-N-[2-(phenylmethyl)phenyl]-

1of3

Eptifibatide non cyclic impurity L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl- Eptifibatide Impurity 10 135900-78-6